Post-doctoral Fellow in the Department of Clinical Oncology, School of Clinical Medicine (Ref.: 533845) (to commence as soon as possible for two years, with the possibility of renewal subject to satisfactory performance and funding availability).
The Department provides an open, supportive, dynamic and motivating academic environment with the possibility to work on the cutting-edge research project related to the spatial transcriptome study to identify the biomarkers for cancer metastasis. The activities of the appointee will be integrated in a multidisciplinary team.
Applicants should possess a Ph.D. degree in Cancer Biology, Biomedical Sciences or a related discipline, with a good research publication record. Preference will be given to those with previous experience in one or more of the following areas: functional studies for tumor suppressors and oncogenes using mouse models, functional studies for the immune cells in tumor microenvironment and cancer biomarker analysis and drug testing in vitro and in vivo. Applicants should be self-motivated, able to work independently as well as in a team, and able to help supervise Ph.D. students. They should also have excellent communication skills in written and spoken English, good trouble-shooting skills, and effective collaboration skills.
The appointee will join a multidisciplinary team to work on the functional studies for the candidate genes/immune cell types identified from the spatial transcriptome study and perform any duties assigned by the supervisor. The appointee will get training in single-cell RNA sequencing analysis, spatial transcriptome data analysis and genomic analysis for multi-omics studies.
A highly competitive salary commensurate with qualifications and experience will be offered. Other benefits include annual leave, medical benefits and free access to on-campus gyms and libraries.
The University only accepts online application for the above posts. Applicants should apply online at the University’s Careers site (https://jobs.hku.hk) and upload an up-to-date C.V., 2 reference letters and a cover letter outlining research experience and publication record. Review of applications will start as soon as possible and continue until December 31, 2025, or until the post is filled, whichever is earlier.
The University is an equal opportunities employer and
is committed to equality, ethics, inclusivity, diversity and transparency
